MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis

Status Completed

Clinical Trial Summary

The purpose of this study is to access the efficacy of MMF compared to CTX in inducing remission and improving renal function in subjects with ANCA associated vasculitis with renal involvement.

Clinical Trial Description

The ANCA-associated vasculitides can be life threatening. Glucocorticoids and cyclophosphamide therapy is effective in about 80% patients. However, the side effects such as bone marrow suppression, infection, cystitis, infertility, myelodysplasia preclude further use of cyclophosphamide in some patients and the relapse rate is high.

Recent studies have shown that mycophenolic acid(MPA), the active metabolite of mycophenolate mofetil(MMF), could exhibit multifarious effects on endothelial cells, including inhibition of ICAM-1 expression, neutrophil attachment,IL-6 secretion, and the process of angiogenesis, which contribute to the efficacy of MMF in the treatment of vasculitic lesions such as lupus nephritis with vasculitic lesions. This study was a feasibility study to assess the safety and effectiveness of MMF in inducing remission in subjects with ANCA-associated SVV compared with pulse intravenous cyclophosphamide. After enrollment, subjects were followed longitudinally, and formal measurements of disease activity were determined using the Birmingham Vasculitis Activity Score (BVAS). ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Anti-Neutrophil Cytoplasmic Antibody
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Vasculitis

Clinical Trial Details

NCT number	NCT00301652
Study type	Interventional
Source	Nanjing University School of Medicine
Contact
Status	Completed
Phase	N/A
Start date	June 2003
Completion date	December 2005

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02498808` - Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?	N/A
Completed	`NCT01363388` - A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis	Phase 2
Completed	`NCT00004357` - Absorption of Corticosteroids in Children With Juvenile Dermatomyositis	Phase 2
Recruiting	`NCT05263817` - A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis	Early Phase 1
Recruiting	`NCT05635266` - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed	`NCT01947465` - Immunogenicity and Safety of Vaccinations in Immunocompromised Persons	N/A
Completed	`NCT02240888` - Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response	N/A
Completed	`NCT03693586` - Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
Completed	`NCT05604482` - CXCR4-PET/CT for Diagnosing Giant Cell Arteritis	N/A
Completed	`NCT03765424` - Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis
Recruiting	`NCT06065852` - National Registry of Rare Kidney Diseases
Recruiting	`NCT05383339` - Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
Active, not recruiting	`NCT03755245` - Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis	N/A
Recruiting	`NCT05565885` - Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis
Recruiting	`NCT02593565` - Vasculitis Pregnancy Registry
Recruiting	`NCT02856243` - Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis	N/A
Recruiting	`NCT05628948` - Vascular Lab Resource (VLR) Biorepository
Active, not recruiting	`NCT03692416` - The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children	Phase 3
Completed	`NCT05115370` - Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19
Terminated	`NCT03937856` - Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases	N/A